6IBX
Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 5
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | BESSY BEAMLINE 14.1 |
| Synchrotron site | BESSY |
| Beamline | 14.1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2015-08-18 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 0.91841 |
| Spacegroup name | P 65 2 2 |
| Unit cell lengths | 102.782, 102.782, 254.440 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 47.650 - 2.110 |
| R-factor | 0.1884 |
| Rwork | 0.187 |
| R-free | 0.21990 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3qpu |
| RMSD bond length | 0.012 |
| RMSD bond angle | 1.504 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | REFMAC |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 47.650 | 47.650 | 2.230 |
| High resolution limit [Å] | 2.110 | 6.270 | 2.110 |
| Rmerge | 0.101 | 0.026 | 0.992 |
| Rmeas | 0.107 | 0.027 | 1.049 |
| Number of reflections | 46675 | 2018 | 7261 |
| <I/σ(I)> | 19.26 | 2.27 | |
| Completeness [%] | 99.6 | 99.5 | 97.7 |
| Redundancy | 10.442 | 9.442 | 9.37 |
| CC(1/2) | 0.999 | 1.000 | 0.744 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 277 | 2% Tacsimate, 10% PEG3350, 0.1M MES/imidazole pH 7.0 |






